Latest News, Deals, Pharma
Alexion Acquires Voyager’s Preclinical Capsid for Rare Neurological Disease After $1B Pfizer Transfer
Your One-stop Hub for The Latest Pharma News & Industry Insights
Follow Us On Google NewsMost Recent
Latest News, Deals, Pharma
Alexion Acquires Voyager’s Preclinical Capsid for Rare Neurological Disease After $1B Pfizer Transfer
Pharma, Clinical Trials, Latest News
Vertex Halts Phase 2 Lung Therapy, Reevaluates DMD Drug’s Clinical Path
Latest News, Clinical Trials, Pharma
Ventyx Halts TYK2 Inhibitor Despite Phase 2 Success, Stock Plummets 70%
Latest News, Pharma
J&J MedTech Plans US Clinical Trials for Ottava Surgical Robot in Late 2024
Pharma, Clinical Trials, Latest News
Imbria Pharmaceuticals Clears Safety Hurdles in Phase 2 Heart Failure Trial, Paving the Way for Promising Late-Stage Development
October 2023 Layoff Tracker: Biotech & Pharma Sector Shifts
In the ebb and flow of the Biotech and Pharma sectors, workforce adjustments reflect not …
How Germanyâs New Reimbursement Law Is Shaking Up the Pharma Industry
Germany is one of the largest and most influential pharmaceutical markets in Europe, with a …
September Layoffs: A Recap Of Recent Workforce Reductions In Biotech And Pharma
The pharma industry has been facing various challenges in 2023, such as the aftermath of …
Wilms Tumor: What You Need to Know
Let’s discuss about Wilms Tumor. You may wonder what causes this rare disease, how it …
August Layoffs: A Recap of Recent Workforce Reductions in Biotech and Pharma
In recent weeks, several biotech and pharmaceutical companies have announced significant layoffs, reshaping their organizations …
Discover the rare yet aggressive uterine sarcoma, its symptoms, causes, and treatments.
A cancer called uterine sarcoma develops in the uterus’s (the womb’s) muscle or other tissues. …
Unveiling 2023’s Drug Approvals: Beyond Oncology Boundaries
In the ever-evolving realm of oncology of 2023 emerges as a pivotal era characterized by …
Uterine Cancer: What You Need to Know
The pear-shaped organ in the female pelvis where a baby develops during pregnancy, the uterus, …
CAR T-Cell Therapy in Hematological Malignancies: A Breakthrough or a Bust?
Hematological malignancies are cancers that affect the blood, bone marrow, and lymph nodes. They include …
Farxiga/Forxiga: Drug for Diabetes, Heart Failure and Kidney Disease
Farxiga is a brand name in the United States and Forxiga is the brand name …
Humira Biosimilars: Benefits, Availability, Price, Comparison and More
In this article, we will give you an overview of Humira biosimilars, including their benefits, …
How Heartburn Medicine May Increase Your Risk of Dementia
A recent study suggests that long-term use of certain heartburn medicines (acid reflux drugs) may …
Soft Tissue Sarcoma: Symptoms, Types, Causes, Treatment and Future Directions
What is Soft Tissue Sarcoma? Vascular tumors are a type of soft tissue sarcoma that …
Vaginal Cancer: A Comprehensive Guide to Symptoms, Types, Causes, Treatment and More
Vaginal cancer is a rare but serious condition that affects the muscular tube that connects …
Understanding Urethral Cancer: Causes, Symptoms, Diagnosis, Treatment, And Prognosis
Introduction Of Urethral Cancer Urethral cancer is a rare type of cancer that affects the …
Endometrial Cancer: Symptoms, Risks, and Treatments
Endometrial cancer is the most common type of uterine cancer. Find out what causes it, …
Trodelvy: The New Hope for Breast Cancer Patients
Trodelvy is a brand name for sacituzumab govitecan-hziy, a new type of drug that combines …
Results from Garsorasib Expand the Class of KRASG12C Inhibitors in NSCLC
Early findings from the use of garsorasib (D-1553), an oral KRASG12C inhibitor, in patients with …
Enhertu in Breast Cancer: A Breakthrough Treatment for HER2-Positive and HER2-Low
This blog post will review how Enhertu in breast cancer works, how it is used, …
Weighing the benefits and drawbacks of the newest Weight loss medication as well as their financial impact
Weight Loss Medication: Obesity rates in the United States have significantly increased since the 1980s, …
The UK is looking into GLP-1 medications made by Novo Nordisk, AstraZeneca, Lilly, and Sanofi for GLP-1 inhibitor suicide risk
Following the European Union’s lead, the United Kingdom has initiated an investigation into the potential …
Bispecific Antibodies in Multiple Myeloma: A Combination Leads to Durable Responses
Bispecific antibodies in multiple myeloma are a new class of drugs that can target two …
Research-Driven Design to Enhance the Patient Experience
Imagine you are a patient needing medication for a chronic condition. You open the package …
Multiple Myeloma: What You Need to Know About the Latest Advances
Multiple myeloma is a type of blood cancer that affects plasma cells, which are responsible …
How BCMA-targeted therapies are changing the game for multiple myeloma
Imagine a world where you could treat cancer with a simple injection or infusion, without …
FDA-Approved Medications for Multiple Myeloma: What You Need to Know
Let’s find out FDA-approved medications for multiple myeloma. Multiple myeloma is a type of blood …
Daratumumab in Multiple Myeloma: What You Need to Know
Multiple myeloma is a serious and incurable blood cancer that affects millions of people worldwide. …
Medtronic, Edwardsâ TAVR devices match surgery in long-term studies
At the Transcatheter Cardiovascular Therapeutics conference in San Francisco, both Medtronic and Edwards Lifesciences unveiled …
Abbottâs Amulet, Bostonâs Watchman equal in heart occluder trial
The study, presented as a late-breaking feature at the Transcatheter Cardiovascular Therapeutics conference in San …
Daiichi and AstraZeneca expand ADC pipelines after Enhertu triumph
At the European Society for Medical Oncology (ESMO) Congress, Daiichi Sankyo made a significant impact …
Moderna, BioNTech face hurdles in cancer vaccine production after COVID success
Moderna and BioNTech, both navigating their post-COVID future while reimagining cancer treatments, have encountered manufacturing …
Keytruda: Merckâs breakthrough cancer drug with mixed results at ESMO
Merck & Co. made significant strides at this year’s European Society for Medical Oncology (ESMO) …
BioNTechâs CAR-T/CARVac Combo Shows High Response Rates in Solid Tumors, But Also Higher Toxicity (ESMO 2023)
ESMO 2023: LBA35 BioNTech’s innovative manufacturing process for CAR-T therapy, BNT211, has shown promising results …
Dato-DXd Shows Efficacy in Lung Cancer, But Safety Issues Remain (ESMO 2023)
ESMO 2023: LBA12 During the Presidential Symposium at the ESMO Congress 2023 in Madrid, a …
Pluvicto Improves Survival in Earlier Prostate Cancer, But Faces Regulatory Hurdles (ESMO 2023)
ESMO 2023: LBA13 Novartis is eagerly advancing its radiotherapy drug, Pluvicto, with aspirations of its …
Ambrxâs ARX517 Shows Promising Efficacy and Safety in Advanced Prostate Cancer (ESMO 2023)
ESMO 2023: 1804P As of the data cutoff date in September 2023, the results from …
Merusâ Zeno Shows Higher Response Rates in NRG1+ Pancreatic and Lung Cancers (ESMO 2023)
ESMO 2023: 1618P Currently, Ipsen’s Onivyde is the standard of care, but it offers only …
Imfinzi and Lynparza Combo Improves Survival in Endometrial Cancer Trial (ESMO 2023)
ESMO 2023: LBA41 AstraZeneca is exploring a potentially powerful approach in the fight against endometrial …
Discover the World of Pharma with Pharmtales.com: Your Ultimate Latest Pharma News and Insights Platform
Welcome to Pharmtales.com, your ultimate pharma news and insights platform. Here you will find the latest pharma news, pharma industry news, health and pharma news, and more. Whether you are a pharma professional, a health enthusiast, or a curious reader, you will find something interesting and useful on our website.
Pharmtales.com is dedicated to bringing you the most relevant and reliable information about the pharma world. We cover topics such as drug development, clinical trials, regulatory approvals, market trends, business strategies, innovation, and more. We also feature interviews with experts, opinions from industry leaders, and analysis from our team of writers.
Our mission is to inform, educate, and inspire you with the stories of pharma. We want to help you discover the world of pharma and its impact on health and society. We hope you enjoy reading our latest pharma news and articles to stay updated every day. Pharmtales.com: Pharma News and Insights You Can Trust.
RSS Feed
- Pfizer has transferred an AAV capsid designed for a rare neurological disease target to AstraZenecaâs…
- Vertex Pharmaceuticals anticipates a âmilestone-rich periodâ ahead, but there are updates regarding two of its…
- Ventyx Biosciences discovered that even a seemingly successful clinical trial may not be enough to…
- Johnson & Johnson MedTech has set a new timeline for the development of its highly…
- Imbria Pharmaceuticals has achieved positive results in a phase 2 trial for its heart failure…
- Zimmer Biometâs executive branch experienced significant changes in the third quarter, but these transitions havenât…
